Due to regulatory requirements, a stack of issues surface for pharmaceutical companies when it is time to add an application.
Solvay Pharmaceuticals, now owned by Abott, found itself adding three servers every time it added an application. The company was required to keep separate server environments for development, test and production. Over time, server sprawl became a significant issue.
The company turned to virtulalization for its answer. The results speak for themselves.
How A Pharmaceutical Company Achieved 25:1 Server Consolidation
